People who join the Personalised Breast Cancer Programme (PBCP), funded by Cancer Research UK and The Mark Foundation for Cancer Research, as part of the MFICM, have their DNA read like a barcode, with the whole genome of their tumour sequenced and the results returned within six to 12 weeks to inform treatment planning.
Following the success of the programme in Cambridge, there are now plans for it to open at up to 10 other sites across the country by the end of 2022. The first of those has opened this month – Breast Cancer Awareness Month – in Oxford.
Photo credit: National Human Genome Research Institute.
This story has been covered in Cambridge media and Oxford media.
